Drug Research
Pharmacopoeias To Aid Vaccine Creation And Research Further
The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger RNA (mRNA) vaccines.
The first job for the newly formed Working Party will be to produce...
Drug Research
AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod
AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way for billions in sales.
This is the first-ever U.S. Food and Drug Administration (FDA) approval for...
Drug Research
GenKOre- Korea Creating Base-Editing Tech For Genetic Issues
Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method.
The hypercompact ABEs created by GenKOre are distinguished by their small size, ability to be delivered via an adeno-associated virus...
Drug Research
NICE Has Granted Its Endorsement To Beovu From Novartis
Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form of the guidance, brolucizumab, also known as Beovu, is suggested as a treatment for adults...
Drug Research
Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill
Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy studying the information at hand to determine how the legislation would impact the leading companies...
Drug Research
September May Bring Updated COVID-19 Booster Shots To Market
According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus subvariants may be made accessible in the early fall, subject to approval by federal health...
Drug Research
Zoryve Cream By Arcutis Receives FDA Approval For Psoriasis
Pfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment never took off because of adverse reactions and funding problems. Arcutis Biotherapeutics, a young biotech company, is now introducing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read